Overview
Melissa Nott Davis and Thomas Steindler continue defending Sandoz Inc. as one of two pharma companies that were given antitrust immunity by a Massachusetts federal court in litigation over a generic blood clot medication. The plaintiff company is asking the First Circuit to revive its suit.
